Zila launches oral cancer test in UK:
This article was originally published in Clinica
Zila Biomedical, the Phoenix, Arizona-based diagnostics manufacturer, is launching its OraTest, oral cancer test in the UK, through its licensee and distributor, Stafford-Miller. The test is a five-minute mouthwash shown to be 100% accurate for squamous cell carcinoma. Survival rate for the disease is only 53% after five years, but the makers claim the test can detect the condition even in the pre-symptomatic stage. The kit is marketed in the UK as OraScreen.